Free Newsletter
How to merge Roche and Genentech
Free newsletter via e-mail
Tools
Want a primer on the legal ins and outs of Roche's bid for Genentech? We don't blame you. Between state and federal laws and the two companies' own affiliation agreement, the deal could get pretty complicated. Luckily, DealBook has obliged. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: